Nuvation Bio Market Sentiment

Nuvation Bio Inc

NUVBNYSE

Trade with Public

$4.85

0.08451.77%

Últ. Act.: Oct 20, 6:47 PM

$4.85

0.08451.77%

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Comparar Opciones Informe de acciones

Nuvation Bio Market Sentiment - Benzinga

Nuvation Bio Market Sentiment

Market sentiment signals for Nuvation Bio (NUVB): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 27.6% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

18 analysts

Options Flow (P/C)

—

Avg Consensus PT

$11

+124.1%

Highest Price Target

$21

+332.6%

HC Wainwright & Co.

Lowest Price Target

+3.0%

RBC Capital

Short Interest

27.6%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 30, 2026	Citigroup	Geoff Meacham—	+147.2%	$12	Initiate	Buy
Sep 16, 2026	Citizens	Silvan Turkcan—	+106.0%	$10 → $10	Maintained	Market Outperform
Sep 16, 2026	Wedbush	David Nierengarten—	+126.6%	$11 → $11	Maintained	Outperform
Aug 21, 2026	Cantor Fitzgerald	Li Watsek—	—	—	Initiate	Overweight
Aug 18, 2026	JP Morgan	Priyanka Grover—	+167.8%	$13	Initiate	Overweight
Aug 7, 2026	RBC Capital	Leonid Timashev—	+312.0%	$19 → $20	Maintained	Outperform
Jul 27, 2026	HC Wainwright & Co.	Robert Burns—	+332.6%	$17 → $21	Maintained	Buy
Jul 23, 2026	Wedbush	David Nierengarten—	+126.6%	$11 → $11	Maintained	Outperform
Jul 7, 2026	RBC Capital	Leonid Timashev—	+291.4%	$20 → $19	Maintained	Outperform
Jul 7, 2026	Truist Securities	Gregory Renza—	+167.8%	$12 → $13	Maintained	Buy
May 5, 2026	RBC Capital	Leonid Timashev—	+312.0%	$20 → $20	Maintained	Outperform
May 5, 2026	Wedbush	David Nierengarten—	+126.6%	$11 → $11	Maintained	Outperform
May 5, 2026	HC Wainwright & Co.	Robert Burns—	+250.2%	$17 → $17	Maintained	Buy
Apr 16, 2026	Wedbush	David Nierengarten—	+126.6%	$11 → $11	Maintained	Outperform
Apr 2, 2026	Wedbush	David Nierengarten—	+126.6%	$11 → $11	Maintained	Outperform
Mar 27, 2026	Wedbush	David Nierengarten—	+126.6%	$11 → $11	Maintained	Outperform
Mar 3, 2026	UBS	Michael Yee—	+44.2%	$10 → $7	Maintained	Neutral
Mar 3, 2026	RBC Capital	Leonid Timashev—	+167.8%	$12 → $13	Maintained	Outperform
Feb 10, 2026	Wedbush	David Nierengarten—	+126.6%	$11 → $11	Maintained	Outperform
Jan 21, 2026	RBC Capital	Leonid Timashev—	+147.2%	$9 → $12	Maintained	Outperform
Jan 12, 2026	HC Wainwright & Co.	Robert Burns—	+250.2%	$18 → $17	Maintained	Buy
Jan 7, 2026	UBS	Michael Yee—	+106.0%	$10	Initiate	Neutral
Dec 11, 2025	HC Wainwright & Co.	Robert Burns—	+270.8%	$10 → $18	Maintained	Buy
Dec 1, 2025	HC Wainwright & Co.	Robert Burns—	+106.0%	$10 → $10	Maintained	Buy
Nov 24, 2025	Truist Securities	Gregory Renza—	+126.6%	$11	Initiate	Buy